Skip to main content
news
 A container ship passes Shell's Pulau Bukom refinery in Singapore November 17, 2020. REUTERS/Edgar Su

 

U.S. law firm Latham & Watkins has advised PT Chandra Asri Pacific, Indonesia's largest chemical and infrastructure solutions company, as part of a consortium buying Shell Energy and Chemicals Park Singapore (SECP) from Shell Singapore.

Shell will sell its entire interest in SECP to CAPGC, a joint venture that is majority-owned and operated by Chandra Asri and minority-owned by Glencore Asia Holdings through their respective subsidiary companies. The deal is valued between $600 mln and $1 billion, according to reports.

This divestment by Shell is the outcome of a strategic review of its energy and chemicals park assets on Bukom and Jurong Island in Singapore that began in June 2023. The review was in response to the ongoing high-grading of Shell Group’s chemicals and products portfolio, changing market conditions, and enhanced capital discipline, Shell said in a statement.

The Latham team was led by Singapore partner Timothy Hia and London partner Simon Tysoe and included Singapore counsel Carolyn Wong, Singapore associates David Shin, Cher Lin Chin, and Andrew Lee, and London associate Emily Smith.

Advice was also provided on project and finance matters by Singapore partner Owain Davies, and on antitrust matters by Brussels partner Luca Crocco.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

WongP acts on $1.8 bln KSA-Singapore agribusiness deal

Big Four Singapore law firm WongPartnership has advised food and agribusiness company Olam Group on the sale of a controlling 44.58 percent stake to Saudi Arabia’s SALIC for $1.78 billion.

Paul Hastings, Weil acting on $23 bln Panama canal deal: Bloomberg

Weil Gotshal & Manges is advising a BlackRock-led investor group on its $22.8 billion agreement to buy a majority stake in Hong Kong's CK Hutchison, which runs ports along either side of the Panama Canal, Bloomberg has reported.

CAM, Anagram, K Law, Quillon, STB act on KKR’s $400 mln HCG acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas and Simpson Thacher & Barlett have advised private equity firm KKR on its $400 million acquisition of a majority stake in Indian hospital chain Healthcare Global (HCG) from PE firm CVC, who was represented by its longstanding legal advisor Anagram Partners.